Last Updated: 2026

Turning Point Therapeutics

Summary

Summary

Turning Point Therapeutics, Inc. is a clinical-stage precision oncology company with a robust pipeline of internally developed drug candidates. The company is focused on discovering and developing novel therapies to address key limitations of existing treatments, including the emergence of drug resistance, to significantly improve the lives of patients with cancer.

History

Headquartered in San Diego, California, Turning Point Therapeutics was founded in 2013 by a team of oncology scientists from La Jolla Pharmaceuticals. The company is actively researching and developing novel and targeted therapies targeting newly identified genetic and epigenetic alterations in cancer cells.

Mission

Turning Point Therapeutics’ mission is to discover and develop precision oncology therapies to improve the lives of our patients and improve their clinical outcomes.

Vision

Turning Point Therapeutics pursues a vision of a world in which early, targeted treatments are the standard of care for cancer, allowing people to live longer, healthier lives.

References

https://in.investing.com/equities/turning-point-therapeutics-inc

https://www.crunchbase.com/organization/tp-therapeutics

www.tptherapeutics.com

Leadership team

J. Jean Cui (Founder)

Y. Peter Li (Founder)

Products / Services

Biotechnology, Health Care, Pharmaceutical, Therapeutics

Number of Employees

100 - 500

Address